DrugPatentWatch Database Preview
Investigational Drug Information for LDK378
Email this page to a colleague
What is the drug development status for LDK378?
LDK378 is an investigational drug.
There have been 31 clinical trials for LDK378.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 11th 2015.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, and Neoplasms. The leading clinical trial sponsors are Novartis Pharmaceuticals, National Cancer Institute (NCI), and Novartis.
There are two hundred and thirteen US patents protecting this investigational drug and two international patents.
Summary for LDK378
| US Patents | 213 |
| International Patents | 2,342 |
| US Patent Applications | 1,068 |
| WIPO Patent Applications | 988 |
| Japanese Patent Applications | 296 |
| Clinical Trial Progress | Phase 2 (2015-12-11) |
| Vendors | 81 |
Recent Clinical Trials for LDK378
| Title | Sponsor | Phase |
|---|---|---|
| Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer | NRG Oncology | Phase 2 |
| Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer | National Cancer Institute (NCI) | Phase 2 |
| A Study of LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement | Yonsei University | Phase 2 |
Clinical Trial Summary for LDK378
Top disease conditions for LDK378
Top clinical trial sponsors for LDK378
US Patents for LDK378
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LDK378 | ⤷ Sign up for a Free Trial | Low, immune enhancing, dose mtor inhibitors and uses thereof | Novartis AG (Basel, CH) | ⤷ Sign up for a Free Trial |
| LDK378 | ⤷ Sign up for a Free Trial | Polycyclic inhibitor of anaplastic lymphoma kinase | XUANZHU PHARMA CO., LTD. (Jinan, Shandong Province, CN) | ⤷ Sign up for a Free Trial |
| LDK378 | ⤷ Sign up for a Free Trial | .beta.-substituted .beta.-amino acids and analogs as chemotherapeutic agents and uses thereof | Quadriga Biosciences, Inc. (Los Altos, CA) | ⤷ Sign up for a Free Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LDK378
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LDK378 | Australia | AU2014348657 | 2033-11-13 | ⤷ Sign up for a Free Trial |
| LDK378 | Australia | AU2017245411 | 2033-11-13 | ⤷ Sign up for a Free Trial |
| LDK378 | Australia | AU2019246853 | 2033-11-13 | ⤷ Sign up for a Free Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
